This is a community-generated profile. If you work at Alnylam Pharmaceuticals, to claim it.
DiscoverStartupsAlnylam PharmaceuticalsAlnylam Pharmaceuticals Funding Rounds, Valuation & Investors
Alnylam Pharmaceuticals company logo
Develops RNAi therapeutics for rare genetic & other diseases501-1000 Employees

Alnylam Pharmaceuticals Funding

$710M
22 rounds
Alnylam Pharmaceuticals is active in the following markets / industries: health care. The company has secured funding across 2 rounds, totaling in an amount of $710M. Their most recent funding was raised on January 13, 2014.

Funding Rounds

U
$700000000
U
$10000000